Combined treatment of achalasia -botulinum toxin injection followed by pneumatic dilatation: Long-term results

Diseases of the Esophagus

Volumn 23, Issue 2, 2010, Pages 100-105

  Kroupa, R ^a   Hep, A ^a   Dolina, J ^a   Valek, V ^a   Matyasova, Z ^a   Prokesova, J ^a   Mrazova, J ^a   Sedmik, J ^a   Novotny, I ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Achalasia; Botulinum toxin; Pneumatic dilatation; Therapy

Indexed keywords

BOTULINUM TOXIN A; OMEPRAZOLE; PROTON PUMP INHIBITOR; MUSCLE RELAXANT AGENT;

ADULT; AGED; ARTICLE; CARDIOESOPHAGOMYOTOMY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DYSPHAGIA; ESOPHAGOGRAPHY; ESOPHAGUS ACHALASIA; ESOPHAGUS DILATATION; ESOPHAGUS MANOMETRY; ESOPHAGUS PERFORATION; FEMALE; FOLLOW UP; HEARTBURN; HUMAN; LAPAROSCOPIC SURGERY; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; REFLUX ESOPHAGITIS; RELAPSE; REMISSION; SCAR FORMATION; SYMPTOM; THERAPY EFFECT; TREATMENT FAILURE; CATHETERIZATION; COHORT ANALYSIS; COMPARATIVE STUDY; DEGLUTITION DISORDERS; DRUG EFFECTS; ESOPHAGEAL ACHALASIA; ESOPHAGEAL PERFORATION; ESOPHAGOSCOPY; LAPAROSCOPY; LONGITUDINAL STUDY; MANOMETRY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; RECURRENT DISEASE; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXINS, TYPE A; CATHETERIZATION; COHORT STUDIES; COMBINED MODALITY THERAPY; DEGLUTITION DISORDERS; ESOPHAGEAL ACHALASIA; ESOPHAGEAL PERFORATION; ESOPHAGEAL SPHINCTER, LOWER; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; HEARTBURN; HUMANS; LAPAROSCOPY; LONGITUDINAL STUDIES; MALE; MANOMETRY; MIDDLE AGED; NEUROMUSCULAR AGENTS; OMEPRAZOLE; PATIENT SATISFACTION; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; RECURRENCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77953163189     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2009.01005.x     Document Type: Article

References (32)

1. Richter J, Yamada T, (eds). Textbook of Gastroenterology. Philadelphia, PA: Lipincott, 1991; 1083-113.
2. Park W, Vaezi M F. Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol 2005; 100: 1404-14.
3. Mearin F, Mourelle M, Guarner F, Papo M, Balboa A, Malagelada J R. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest 1993; 23: 724-8.
4. Verne G N, Sallustio J E, Eaker E Y. Anti-myenteric neuronal antibodies in patients with achalasia. A prospective study. Dig Dis Sci 1997; 42: 307-13.
5. Vaezi M F, Richter J E. Diagnosis and management of achalasia. Practice guidelines. Am J Gastroenterol 1999; 94: 3406-12.
6. Lake J M, Wong R K H. Review article: the management of achalasia -a comparison of different treatment modalities. Aliment Pharmacol Ther 2006; 24: 909-18.
7. Pasricha P J, RavichWJ,Hendrix T R, Sostre Sjones B,Kalloo A N. Intrasphincteric botulinum toxin for the treatment of achalsia. N Engl J Med 1995; 332: 774-8.
8. Gui D, Rossi S, Runfola M, Magalini S C. Review article: botulinum toxin in the therapy of gastrointestinal motility disorders. Aliment Pharmacol Ther. 2003; 18: 1-16.
9. Zarate N, Mearin F, Baldovino F, Armengol J R, Malagelada J R. Achalasia treatment in the elderly: is botulinum toxin injection the best option? Eur J Gastroenterol Hepatol 2002; 14: 285-90.
10. Neubrand M, Scheurlen C, Schepke M, Sauerbruch T. Long term results and prognostic factors in the treatment of achalasia with botulinum toxin. Endoscopy 2002; 34: 519-23.
11. Pasricha P J, Rai R, Ravich W J, Hendrix R T, Kaloo A N. Botulinum toxin for achalasia: long term outcome and predictors of response. Gastroenterology 1996; 110: 1410-5.
12. Annese V, Basciani M, Borrelli O, Leandro G, Simone P, Andriulli A. Intrasphincteric injection of botulinum toxin is effective in long-term treatment of achalasia. Muscle Nerve 1998; 21: 1540-2.
13. Leyden J E, Moss A C, MacMathuna P. Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia. Cochrane Database Syst Rev 2006; 4: CD005046.
14. Muehldorfer S M, Schneider T H, Hochberger J, Martus P, Hahn E G, Ell C. Esophageal achalasia: intrasphincteric injection of botulinum toxin A versus balloon dilatation. Endoscopy 1999; 31: 517-21.
15. Allescher H D, Storr M, Seige M et al. Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-up. Endoscopy 2001; 33: 1007-17.
16. Vaezi M F, Richter J E, Wilcox C M et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomized trial. Gut 1999; 44: 231-9.
17. Zerbib F, Thetiot V, Richy F et al. Repeated pneumatic dilations as long term maintenance therapy for esophageal achalasia. Am J Gastroenterol 2006; 101: 692-7.
18. West R L, Hirsch D P, Bartelsman J F et al. Long term results of pneumatic dilatation in achalasia followed for more than 5 years. Am J Gastroenterol 2002; 97: 1346-51.
19. Karamanolis G, Sgouros S, Karatzias G et al. Long term outcome of pneumatic dilatation in the treatment of achalasia. Am J Gastroenterol 2005; 100: 270-74.
20. Chan K C, Wong S K, Lee D W et al. Short-term and long-term results of endoscopic balloon dilation for achalasia: 12 years' experience. Endoscopy 2004; 36: 690-4.
21. Hep A, Dolina J. Plottova Z, Valek V, Novotny I, Kala Z. Is complex therapy of achalasia using botulinum toxin combined with balloon dilatation an effective approach? Bratisl Lek Listy 2000; 101: 433-7.
22. AGA. Technical review on the clinical use of esophageal manometry. Gastroenterology 2005; 128: 209-24.
23. Mikaeli J, Yaghoobi M, Montazeri G, Ansari R, Bishehsari F, Malekzadeh R. Efficacy of botulinum toxin injection before pneumatic dilatation in patients with idiopatic achalasia. Dis Esophagus 2004; 17: 213-7.
24. Mikaeli J, Bishehsari F, Montazeri G et al. Injection of botulinum toxin before pneumatic dilatation in achalasia treatment: a randomized-controlled trial. Aliment Pharmacol Ther 2006; 24: 983-9.
25. Annese V, Bassotti G, Cocia G et al. Comparison of two different formulations of botulinum toxin A for treatment of esophageal achalasia. Aliment Pharmacol Ther 1999; 13: 1347-50.
26. Arain M A, Peters J H, Tamhankar A P et al. Preoperative lower esophageal sphincter pressure affects outcome of laparoscopic esophageal myotomy for achalasia. J Gastrointest Surg 2004; 8: 328-34.
27. Martinek J, Siroky M, Plottova Z, Bures J, Hep A, Spicak J. Treatment of patients with achalasia with botulinum toxin: a multicenter prospective cohort study. Dis Esophagus 2003; 16: 204-9.
28. Horgan S, Hudda K, Eubanks I, McAllister J, Pellegriani C A. Does botulinum toxin injection make esophagomyotomy a more difficult operation? Surg Endosc 1999; 13: 576-9.
29. Cowgill S M, Villadolid D V, Al-Saadi S, Rosemurgy A S. Difficult myotomy is not determined by preoperative therapy and does not impact outcome. JSLS 2007; 11 (3): 336-43.
30. Bloomston M, Fraiji E, Boyce H W Jr, Gonzalvo A, Johnson M, Rosemurgy A S. Preoperative intervention does not affect esophageal muscle histology or patient outcomes in patients undergoing laparoscopic Heller myotomy. J Gastrointestinal Surg 2003; 7: 181-8.
31. Deb S, Deschamps C, Allen M S et al. Laparoscopic esophageal myotomy for achalasia: factors affecting functional results. Ann Thorac Surg 2005; 80: 1191-4.
32. Liu J F, Zhang J, Tian Z Q et al. Long-term outcome of esophageal myotomy for achalasia. World J Gastroenterol 2004; 10: 287-91.